Compare NTIC & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTIC | CPIX |
|---|---|---|
| Founded | 1970 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.1M | 73.6M |
| IPO Year | 1996 | 2007 |
| Metric | NTIC | CPIX |
|---|---|---|
| Price | $8.58 | $3.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.1K | ★ 110.0K |
| Earning Date | 04-09-2026 | 03-03-2026 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $84,234,474.00 | $42,010,949.00 |
| Revenue This Year | $11.40 | N/A |
| Revenue Next Year | $8.70 | N/A |
| P/E Ratio | $280.00 | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $6.77 | $1.85 |
| 52 Week High | $10.80 | $6.27 |
| Indicator | NTIC | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 41.21 |
| Support Level | $7.32 | $2.95 |
| Resistance Level | $8.58 | $3.69 |
| Average True Range (ATR) | 0.23 | 0.25 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 1.32 | 51.39 |
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.